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RAC65 is a mutant clone of mouse embryonal carcinoma cells, Pl9. which does not undergo terminal differentiation upon treatment with retinoic 
acid (RA). RAC65 cells cxprcss a truncated RA receptor a (RARa) which, however, does not l’ully explain their defect. Here we show that RAC65 
cells exhibit an additional defect in RARa mRNA which may retlcct a defect in RNA splicing. The parental and mutant cells also differ in tbcit 
capacities to bind [“H]RA into nuclear fractions and in expression of cellular RA binding protein (CRABP) mRNA after treatment with RA. The 
combined ata suggest that the defect in RAG5 RARa results in reduced expression of the CRABP gene after RA treatment and, therefore, 
increased Row of RA into the nucleus. 
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1. INTRODUCTION 
Embryonal carcinoma (EC) cell lines provide a model 
system with which to analyze molecular mechanisms of 
early embryonic determination and differentiation [I]. 
The EC cell line, P19, can be induced to differentiate 
into neurons and glia when treated with retinoic acid 
(RA) [2]. RA functions through at least two distinct 
classes of nuclear eceptors which belong to the steroid/ 
thyroid hormone receptor family: RA receptors 
(RARs), including RARa. RAR,8, and RARy, and the 
retinoic X receptors (RXRs) [3-51. 
The multiplicity of receptor subtypes underscores the 
need for a genetic approach to address their function. 
Recently, several groups have described that the PI9 
EC-derived RA-non-responsive mutant cells, RAC65. 
express atruncated RARa receptor [6-93. Expression of 
the truncated RARa was, however, insufficient o fully 
confer RA non-responsiveness, uggesting that RAC65 
cells carry another mutation(s) affecting RA-inducible 
genes [7]. To determine the additional defect(s) we set 
out to analyze biochemical changes induced in RAC65 
cells by RA. 
2. MATERIALS AND METHODS 
2.1. Cd/ arfrtr~es 
The origin and properties 01’ the mouse EC cell lines (Pl9Xl and 
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sponsivc element. 
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RAC65) have been described [IO-131. Cells were cultured in a I:! 
mixture of Eagles’ minimal essential medium, supplemented with non- 
essential amino acids, 3 mM t.-giutamine 311d i r&l sodium pyruvate 
(11-MEMd). and RPMI-1640 medium. This medium was further sup 
plementcd with penicillin (ItlO U/ml), streptomycin (lOO,f@nl), extra 
glucose (2.5 mdml). and 10% (v/v) beat-inactivated fetal calf serum. 
The cells were M,*cq~/rrsrrra f ee as determined by Hoechst staining 
[14]. To induce differentiation, the cells were harvested, washed and 
plated into culture medium supplemented with all-frufrs RA (Sigma). 
The cells were harvested and exposed to TEG04 antibody [IS] 
(ascitos fluid diluted I:100 in culture medium) for ?.O min at room 
temperature, then wasbed and treated with swine anti-mouse IgG 
conjugated with Huorescein sothiocyanatc @SOL, Praha). The anal- 
ysis wrs performed on a FACScan apparatus (Becton Dickinson). 
Total cellular RNA was isolated by the lithium chloride-urea procc- 
dure [16]. Poly(A)’ RNA was selected by oligo.(dT) cellulose chrom- 
atography as described [ 171. RNA was fractionated on 1% formaldc- 
hydc agarose gels and blotted onto nylon mcmbrrrnes (Hybond N; 
Amersham). The Eltcrs were hybridized with cDNA probes lnbeled 
with [a-“P]dATP by the random priming method [17]. As probes we 
used a 2.1 kb IGECORI fragment of mRARa cDNA, a 1.95 kb 13uaraHI 
fragment of mRARP cDNA, 3 2.0 kb f&R1 fragment of RARy 
cDNA [lg]. a 0.5 kb &oRI-I-llrrdlll fragment of cellular RA binding 
protein (CRABP) cDNA [19], and a 1.6 kb Psrl fragment of rat 
a-tubulin cDNA [20], Hybridization was performed at 42OC in 50% 
formamide using ‘Church’ bufTer [21] supplemented with 0.5% low-fat 
milk, and salmon testes DNA (Sigma). The filters were washed in 2 
x SSC. 0.1% SDS (4 x IO rnin, room temperature) followed by 0.1 x 
SSC. 0.1% SDS (I x 30 min at room temperature and 1 x 30 min at 
65°C). After uutoradiogmphy, the blots were stripped in 0.1 xTE, pH 
8.0,0.05% SDS for 60 min at SO”C and sequentially m-hybridized with 
other cDNA probes. 
7 4 Rctirruic acid rrornkc _. . 
Cells (5 x IOs) w&e placed in culture medium into 60 mm culture 
dishes and cultured for 24 h after which the medium was changed for 
medium with I PM RA or without RA. After another 24 h, the cells 
wcrc washed and cultured for 3 h in serum-free medium supplemented 
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with 7.2 nM [I 1,)2-?i(N)]retinoic acid (2060.9 GBq/mmol; NEN 
Research Products). Nuclear extract and cytosol were isolated as de- 
scribed [22]. Radioactivity of the extracts was measured in 5 ml of a 
scintillation liquid (SLD-31, Chcmopctrol. Spolana Ncratovice). Pro- 
tcin concentrations were assayed by the Coomassie blue protein assay 
[23]. 
2.5. Trunsfictiut~ oruf cklorutrtpkcrricml ucctyi trutnfcruse (CA T) assq 
Transfcction of plasmids into the cells was performed as described 
before [24]. 48 h after transfection the cells were tested in a CAT assay 
[I 71. Efficiency of transfection was monitored by &talactosidasc ac- 
tivity [25]. 
3. RESULTS AND DISCUSSION 
In a previous paper we have described that both 
P19Xl and RAC65 cells express on their surfaces 
SSEA-IITEC-1 and TEC-4 antigens, and that their ex- 
pression in P19Xl cells is down-regulated by RA [I 51. 
When treated with RA, RAC65 cells exhibited neither 
changes in morphology nor a decrease in the expression 
of SSEA-l/TEC-I ([12], our unpublished observations). 
TEC-4 is a more sensitive marker of EC cell differentia- 
tion than SSEA-l/TEC-1 [IS] and, therefore, we ana- 
lyzed TEC-4 expression in untreated and RA-treated 
RAC65 cells. Data presented in Fig. 1 show that RA 
induced a decrease in the expression of TEC-4 in 
RAC65 cells, however, this decrease was less extensive 
than that observed in P19XI cells. This indicates partial 
responsiveness of RAC65 cells to RA; similar results 
were obtained with RAC65 subclones (not shown), ex- 
cluding a role for RA-sensitive revertants in this differ- 
entiation. 
RAC65 cells have been shown to carry a rearrange- 
ment affecting a gene encoding RARa [?I. Furthermore, 
it has been described that the level of expression of the 
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Fig. I. Flow cytotluorimctric analysis of the expression of TEC-4 
antigen in untreated (C) and RA-treated (RA, 0.5yM. 3 days) Pl9Xl 
or RACG5 cells. The cells were labeled by indirect immunofhtores- 
ccnce using TEC-04 as a first layer antibody and Ruorcsceinotcd swine 
anti-mouse IgG as second layer antibody. A histogram obtaincci with 
RA-treated cells labclcd with the second layer antibody only h also 
shown (0). 
normal RARa transcripts is dependent on the way 
RAC65 cells are cultured [S]. To determine whether 
RAC65 cells used in these experiments express an unu- 
sual RARa transcript, Northern blots of total RNA 
were hybridized with mouse RAR-specific cDNA 
probes. As shown in Fig. 2, RACBS cells expressed two 
usual RARa transcripts of 3.0 and 4.0 kb, and a smaller 
transcript of 2.3 kb (RARa’). Surprisingly, the probe 
used also bound to a transcript of 9.1 kb. Neither the 
2.3 nor 9.1 transcripts were present in RNA prepara- 
tions from P19 EC cells. Unusual transcripts in RAC65 
cells were also observed on Northern blots with 
poly(A)+ RNA (Fig. 3, lanes c); the differences between 
RAR y RARU 
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Fig. 2. Northcm blot analysis of RARa. RARP, and RARy mRNA in P19Xl and RAC65 eells. (Lanes a) 20~8 total RNA isoiated from P19Xi 
cells; (lanes b) 20 ~46 total RNA isolated from RAGS cells: (lanes c) 4 ,~g poly(A)’ RNA isolated from RACGS cells. Membrane was sequentially 
probed with cDNA probes for mRARa. mRARP. mRARy and a-tubulin (Tub). (Lunc d) 3Oyg total RNA isolated from RAC65 cells cultured 
for I4 days in medium with RA. The position of I8 S and 28 5 ribosomal RNA is indicated. 
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Fig. 3. Northern blot analysis of RARa and RARP mRNA in RAC65 
cells untreated (lane a) or treated for 24 h with RA at aconcentration 
ofO.1 PM (lane b), 1 yM (lane c) or IO,uM (lane d). 20,~~ total RNA 
was used per lane. Membrane was probed as described in Fig. 2. 
total and poly(A)* RNA probably reflect different affin- 
ities of various RARa and RARy transcripts to oligo- 
(dT) cellulose. The same unusual RARlx transcripts (2.3 
and 9.1 kb) were observed in RAC 65 cells which were 
subcultured for two weeks in the presence of 1 ,tdM RA 
(Fig. 2d). The 9.1 kb RNA transcript in RAC65 cells, 
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Incorporation of yH]RA into cytosol and uuclear extracts 
Cells Pretrealment [‘H]RA incorporation (dpm&g) 
with RA (I ,uM) 
Cytosol NUCleii~ extract 
P19Xl 1042 3 220 + 4 
+ 1102 5 122 8 
RAC65 IlOf. 5 319 f 4 
+ Ia2 f I4 562 f 31 
Untreated (-) or RA-trealed cells (+) were incubated with [“I-l]RA and 
the uptake of radioactivity into cytosol and nuclear c%LracLs were 
determined as described in section 2.4. The values are means ? S.E.M. 
from three experiments performed in triplicate. 
observed in all RNA isolates from RAC65 cells (7 inde- 
pendent isolates) and RAC65 subclones (4 isolates), was 
not described in previous studies [6-91. Thus, RAC65 
sublines cultured under our conditions differ from the 
sublines analyzed in other laboratories. 
RAC65 cells, like PI9 cells, expressed normal RARy 
transcripts and did not express the RARP transcript. 
Upon treatment of RAC65 cells with RA, the levels of 
all four RARa transcripts and RAR/? transcript were 
enhanced (Fig, 3), supporting previous data on partial 
transcriptional induction of RARa and RAR/? genes in 
these cells [6,7]. This induction is probably related to a 
Cells P19Xl RAC 65 
CAT gene TRE2 Gl7-2 TRQ_._._ Ge?_+ _-..-. ^__.. -- 
RA -l---k---- i-s 
Fold- 
induct ion 8.9 IS,1 1.4 1.5 
Fig. 4. Function of the endogenous RARs in RACGT cells. Pl9XI or cells were with 8 of reporter plasmids, (TRE.?),-tk- 
CAT [Ia] or G17-2-CAT [26], and 2 ,ug of&galactosidase l&Z gene under the control of human cytomcgalovirus promoter [28], The indicated 
samples were treated with RA (1 PM) and cell cxtract$ were assdyed for CAT and@galactosidase activity (set section 2.5). Result5 are representative 
of a typical experiment of 8 performed. 
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Fig. 5. Northern blot analysisoTCRAE3PmRNA inP19XI (Iancsa,b). 
RAC65 (lanes c,d) or RAC65 subcultured for two weeks in I /IM RA 
(lanes e.f). The cells were cultumti in the sbscnce (a.c,c) or in the 
presence or I PM RA for 40 Ii. 25 ,& total RNA was loaded per slot. 
Membrane was hybridized with an EcoRI-Hirtdlll liagment of 
CRABP cDNA and rchybridized with the a-tubulinc probe (Tub). 
The position of 13 S ribosomal RNA is indicated. 
partial RA-induced decrease in the expression of TEC-4 
antigen in these cells. 
To verify that RA receptors in RAC65 cells are una- 
ble to activate transcription from synthetic RA-respon- 
sive elements (RAREs), we performed CAT assays 
using two different reporter plasmids: (TRE3),-tk-CAT 
[ 181 and G 17-&CAT [26]. The data presented in Fig. 4 
indicate that transcription from both reporter genes 
transfected into PlYXl cells was dependent on the pres- 
ence of RA (8.9- and 15.I-fold induction). However, 
although RAC65 cells were comparably transfectable 
with P19X1 cells, as determined by ,&galactosidase 
assay, transcription from both reporter genes in RA- 
treated was reduced and S-fold 
Thus, cells under con- 
exhibit in ability initiate 
scription synthetic as result a 
in RARa. Similar results were obtained by other groups 
[7-91. 
RAC65 cells express a mutant protein, RARE’, that 
is 70 amino acids shorter than the wild-type receptor. 
These amino acids were lost from the C-terminal region 
that contains the RA-binding domain [7,9]. To deter- 
mine whether RACBS cells exhibit a defect in RA up- 
take, we compared incorporation of [3H]RA into cy- 
tosol and nuclear extracts from untreated and RA- 
treated P19 and RAC6S cells and their subclones. Data 
presented in Table I indicate that the incorporation of 
[31-l]RA into cytosol was similar in both cell lines, and 
that pretreatment of the cells with RA had no effect on 
this parameter. Pretreatment of RA-responsive cells 
(P19X I) and RA-non-responsive cells (RAC65) in- 
duced, respectively, a decrease and an increase in 
[3H]RA uptake into nuclear extracts. 
The increased binding of [3H]RA into nuclear ex- 
tracts of RACBS cells could result from an additional 
mutation in these cells, as predicted previously [7], or 
could reflect inability of RA-treated RAC6S cells to 
initiate transcription from the CRABP gene [19,27]. To 
distinguish between these two possibilities we analyzed 
CRABP mRNA in untreated and RA-treated P19Xl 
and RACGS cells. Data presented in Fig. S show that 
RAC6S cells are defective in their ability to express the 
CRABP gene after treatment with RA. This defect is 
deeper in cells subcultured for two weeks in 1 yM RA 
(Fig. 5e.f). 
The combined data suggest hat the defect in RARa 
in RAC6S cells results in reduced expression of the 
CRABP gene after treatment with RA and, therefore, 
increased flow of Rh into the nucleus. 
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